2000
Decline in Self-Reported High-Risk Injection-Related Behaviors Among HIV-Seropositive Participants in the Baltimore Needle Exchange Program
Vertefeuille J, Marx M, Tun W, Huettner S, Strathdee S, Vlahov D. Decline in Self-Reported High-Risk Injection-Related Behaviors Among HIV-Seropositive Participants in the Baltimore Needle Exchange Program. AIDS And Behavior 2000, 4: 381-388. DOI: 10.1023/a:1026406623736.Peer-Reviewed Original ResearchNeedle exchange programsHIV-seropositive drug usersDrug usersRisky drug use behaviorsHigh-risk injection practicesInjection-related behaviorsHIV-seropositive individualsHIV-seropositive participantsBaltimore Needle Exchange ProgramDrug use behaviorsNEP participantsDrug treatmentInjection practicesNEP attendanceMean numberVisitsT-testSignificant reductionExchange programsBaselineChi-square statisticsInjectionSyringesParticipantsFollow
1995
Medical Eligibility, Comprehension of the Consent Process, and Retention of Injection Drug Users Recruited for an HIV Vaccine Trial
Harrison K, Vlahov D, Jones K, Charron K, Clements M. Medical Eligibility, Comprehension of the Consent Process, and Retention of Injection Drug Users Recruited for an HIV Vaccine Trial. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1995, 10: 386-390. PMID: 7552502, DOI: 10.1097/00042560-199511000-00012.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAIDS VaccinesClinical Trials as TopicComprehensionConsent FormsDouble-Blind MethodEducational StatusEligibility DeterminationFemaleHIV InfectionsHumansInformed ConsentMaleMiddle AgedPatient SelectionResearch DesignResearch SubjectsSubstance Abuse, IntravenousSurveys and QuestionnairesConceptsInjection drug usersHIV vaccine trialsVaccine trialsDrug usersHuman immunodeficiency virus (HIV) infectionImmunodeficiency virus infectionPhase II trialInformed consent procedureConsent proceduresII trialVirus infectionHigh riskMedical reasonsMedical eligibilityTrialsConsent processEnrollmentFollowInfectionFalse testVisits
1993
Detection of Human Immunodeficiency Virus Type 1 Infection by Polymerase Chain Reaction in a Cohort of Seronegative Intravenous Drug Users
Farzadegan H, Vlahov D, Solomon L, Muñoz A, Astemborski J, Taylor E, Burnley A, Nelson K. Detection of Human Immunodeficiency Virus Type 1 Infection by Polymerase Chain Reaction in a Cohort of Seronegative Intravenous Drug Users. The Journal Of Infectious Diseases 1993, 168: 327-331. PMID: 8335969, DOI: 10.1093/infdis/168.2.327.Peer-Reviewed Original ResearchConceptsSeronegative intravenous drug usersIntravenous drug usersHuman immunodeficiency virus type 1 (HIV-1) infectionVirus type 1 infectionType 1 infectionPolymerase chain reactionDrug usersHIV-1 infectionHIV-1 antibodiesChain reactionLarge cohortBlood specimensProviral DNAInfectionCohortPCR analysisPersonsSerologyFollowVisitsAntibodiesMonths
1992
T-Lymphocyte Subsets in Intravenous Drug Users With HIV-1 Infection-Reply
Margolick J, Muñoz A, Vlahov D, Solomon L, Astemborski J, Cohn S, Nelson K. T-Lymphocyte Subsets in Intravenous Drug Users With HIV-1 Infection-Reply. JAMA 1992, 268: 2517-2517. DOI: 10.1001/jama.1992.03490180047020.Peer-Reviewed Original Research